| Literature DB >> 31644698 |
Ledimar Brianezi1, Elisabete Ornelas1, Flávia de Sousa Gehrke2,3,4, Fernando Luiz Affonso Fonseca4,5, Beatriz da Costa Aguiar Alves4, Luiz Vinicius de Alcantara Sousa4, Jessica Souza1, Laura Beatriz Mesiano Maifrino1.
Abstract
BACKGROUND: The emergence of coronary heart disease is increased with menopause, physical inactivity and with dyslipidemia. Physical training is known to promote the improvement of cardiovascular functions.Entities:
Mesh:
Substances:
Year: 2020 PMID: 31644698 PMCID: PMC7025313 DOI: 10.5935/abc.20190223
Source DB: PubMed Journal: Arq Bras Cardiol ISSN: 0066-782X Impact factor: 2.000
Antibodies used for protein detection
| Antibody | Dilution | Labeling | Function | Manufacturer |
|---|---|---|---|---|
| MMP2 | 1:250 | Cytoplasm | Collagen remodelling | sc-10736, Santa Cruz® |
| MMP9 | 1:300 | Cytoplasm | Collagen remodelling | sc-6840, Santa Cruz® |
| COX 2 | 1:100 | Cytoplasm | Inflammation | sc-1745 P, Santa Cruz® |
| 8-OHdG | 1:100 | Cytoplasm | Oxidative stress | sc-66036, Santa Cruz® |
Figure 1Immunoexpression of proteins. CS: sedentary non-ovariectomized control; COS: sedentary ovariectomized control; COT: trained ovariectomized control; LDLr-S non-sedentary ovariectomized knockout; LLr-OS: sedentary ovariectomized LDL knockout; LDLr-OT: trained ovariectomized LDL knockout.
Comparison of Cyclooxygenase-2, Volume Density of collagen fibers I and Metalloproteinase type 9, with the groups studied. clinical variables with groups
| Variables | CS | COS | COT | LDL-S | LDL-OS | LDL-OT | p |
|---|---|---|---|---|---|---|---|
| COX-2 | 35.0 (23.9; 46.3) | 46.5 (44.2; 79.7) | 46.1 (31.3; 47.7) | 47.7 (45.8; 63.1) | 87.8 (42.5; 92.4) | 49.4 (49.1; 50.9) | 0.232 |
| Vv [fc I] | 0.21 (0.21; 0.43) | 0.43 (0.21; 0.43) | - | - | 0.21 (0.0; 0.41) | 0.0 (0.0; 0.21) | < 0.001 |
| MMP9 | 44.7 (40.1; 44.8) | 40.9 (39.8; 45.6) | 53.9 (48.6; 66.2) | 53.0 (38.3; 58.1) | 42.2 (27.3; 53.7) | 64.1 (45.5; 93.9) | 0.169 |
Kruskal-Wallis. Data expressed as median and 25% and 75% percentiles. COX-2: Cyclooxygenase-2; Vv [fc I]: Volume Density of collagen fibers I; MMP 9: Metalloproteinase type 9; CS: sedentary non-ovariectomized control; COS: sedentary ovariectomized control; COT: trained ovariectomized control; LDL-S: non-sedentary ovariectomized LDL knockout; LDL-OS: sedentary ovariectomized LDL knockout; LDL-OT: trained ovariectomized LDL knockout.
statistically significant difference between the studied group and the COS group;
statistically significant difference between the studied group and the TOC group;
statistically significant difference between the studied group and the LDL-S group.
Comparison of the variables Metalloproteinase type 2, Anti-8-Hydroxydeoxyguanosine and Volume Density of collagen fibers III (Vv [fc III]), with the groups studied.
| Variables | CS | COS | COT | LDL-S | LDL-OS | LDL-OT | p |
|---|---|---|---|---|---|---|---|
| MMP 2 | 28.5 (4.0) | 35.3 (9.1) | 49.0 (3.8) | 54.8 (52.0) | 40.5 (9.6) | 46.8 (31.0) | < 0.001 |
| 8-OHDg | 105.2 (7.6) | 70.0 (10.8) | 64.9 (4.7) | 51.7 (0.5) | 15.3 (7.5) | 38.7 (8.4) | < 0.001 |
| Vv[fc III] | 0.007 (0.037) | 0.003 (0.024) | 0.016 (0.067) | 0.015 (0.057) | 0.013 (0.062) | 0.009 (0.043) | 0.649 |
ANOVA. Data expressed as mean and standard deviation.
statistically significant difference between the studied group and the CS group;
statistically significant difference between the studied group and the COS group;
statistically significant difference between the studied group and the TOC group;
statistically significant difference between the studied group and the LDL-S group;
statistically significant difference between the studied group and the LDL-OS group.
MMP2: Metalloproteinase type 2; 8OHdG: Anti-8-Hydroxydeoxyguanosine; Vv [fc III]: Volume Density of collagen fibers III; CS: sedentary non-ovariectomized control; COS: sedentary ovariectomized control; COT: trained ovariectomized control; LDL-S: non-sedentary ovariectomized LDL knockout; LDL-OS: sedentary ovariectomized LDL knockout; LDL-OT: trained ovariectomized LDL knockout.